|Bid||115.00 x N/A|
|Ask||117.00 x N/A|
|Day's range||112.00 - 112.00|
|52-week range||39.38 - 146.00|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||275.86|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Zimmer Biomet's (ZBH) second-quarter elective procedure volumes decline across all regions.
Zimmer (ZBH) delivered earnings and revenue surprises of 106.94% and 31.71%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zimmer Biomet (ZBH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.